Xenex Disinfection Services, a provider in UV technology-based disinfection strategies and solutions, today announced that it has been named an approved supplier in the Countess of Chester Commercial Procurement Services (CPS) National Framework Agreement for Decontamination Solutions.
For the first time, public sector organizations including hospitals, police forces, fire and rescue services, educational establishments, hospices, housing associations and other public entities in the UK can easily acquire LightStrike disinfection robots via the Countess of Chester CPS Framework.
LightStrike™ Germ-Zapping Robots™ quickly destroy viruses and bacteria and are used to deactivate pathogens on surfaces that are missed during the room cleaning process. The robots emit high intensity bursts of broad spectrum ultraviolet (UV) light proven to deactivate greater than 99.99% of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19, in 2 minutes at 1 meter, according to a peer-reviewed study published in Infection Control and Hospital Epidemiology. LightStrike robots are also proven to quickly destroy pathogens including Clostridioides difficile (C.diff), methicillin-resistant Staphylococcus aureus (MRSA or staph), vancomycin-resistant enterococcus (VRE), influenza, and other multi-drug resistant organisms. Different pathogens are susceptible to UV light at different wavelengths. With bursts of broad spectrum UV light (200-315nm) generated by a pulsed xenon lamp, LightStrike robots quickly deactivate viruses and bacteria where they are most vulnerable without damaging surfaces or materials.
The LightStrike robot is designed for speed, effectiveness and ease of use, which allows trained operators to quickly disinfect rooms (including multi-patient wards) without disrupting business operations. More than 40 peer-reviewed studies validating the efficacy of the LightStrike robot disinfection technology have been published in peer-reviewed journals. The robots have been deployed in more than 800 facilities around the world, including hospitals, hotels, schools, government buildings, police stations and correctional facilities, professional sports arenas, and convention centers.
Xenex recently expanded its global presence to include a UK-based direct sales team. Organizations interested in purchasing LightStrike robots via the Countess of Chester Framework should contact firstname.lastname@example.org or email@example.com.
The Countess of Chester CPS is a center of procurement expertise providing strategic and specialist procurement services and advice to NHS trusts, public sector and private sector clients. According to the Countess of Chester CPS, its framework agreements “aim to offer public sector organizations unique access points to goods and services which offer innovation and savings at no cost to access.”
Xenex is focused on developing, manufacturing and commercializing products and services that utilize its proprietary disinfection technologies to eliminate the spread of deadly pathogens that cause infectious diseases. Xenex is backed by well-known investors that include EW Healthcare Partners, Piper Sandler, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit xenex.com.